C13orf24

Revision as of 14:54, 4 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Chromosome 13 open reading frame 24
Identifiers
Symbols C13orf24 ; KIAA1008; PIBF1; RP11-505F3.1
External IDs Template:OMIM5 Template:MGI HomoloGene4628
RNA expression pattern
More reference expression data
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

Chromosome 13 open reading frame 24, also known as C13orf24, is a human gene.[1]


References

  1. "Entrez Gene: C13orf24 chromosome 13 open reading frame 24".

Further reading

  • Szekeres-Bartho J, Barakonyi A, Par G; et al. (2001). "Progesterone as an immunomodulatory molecule". Int. Immunopharmacol. 1 (6): 1037–48. PMID 11407300.
  • Szekeres-Bartho J, Varga P, Pejtsik B (1990). "ELISA test for the detection of an immunological blocking factor in human pregnancy serum". J. Reprod. Immunol. 16 (1): 19–29. PMID 2600930.
  • Szekeres-Bartho J, Faust Z, Varga P (1996). "The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes". Am. J. Reprod. Immunol. 34 (6): 342–8. PMID 8607938.
  • Check JH, Arwitz M, Gross J; et al. (1997). "Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF)". Am. J. Reprod. Immunol. 37 (1): 17–20. PMID 9138449.
  • Check JH, Arwitz M, Gross J; et al. (1997). "Evidence that the expression of progesterone-induced blocking factor by maternal T-lymphocytes is positively correlated with conception". Am. J. Reprod. Immunol. 38 (1): 6–8. PMID 9266004.
  • Harrington JJ, Sherf B, Rundlett S; et al. (2001). "Creation of genome-wide protein expression libraries using random activation of gene expression". Nat. Biotechnol. 19 (5): 440–5. doi:10.1038/88107. PMID 11329013.
  • Rozenblum E, Vahteristo P, Sandberg T; et al. (2002). "A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes". Hum. Genet. 110 (2): 111–21. doi:10.1007/s00439-001-0646-6. PMID 11935316.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Polgar B, Kispal G, Lachmann M; et al. (2004). "Molecular cloning and immunologic characterization of a novel cDNA coding for progesterone-induced blocking factor". J. Immunol. 171 (11): 5956–63. PMID 14634107.
  • Dunham A, Matthews LH, Burton J; et al. (2004). "The DNA sequence and analysis of human chromosome 13". Nature. 428 (6982): 522–8. doi:10.1038/nature02379. PMID 15057823.
  • Polgár B, Nagy E, Mikó E; et al. (2005). "Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome". Biol. Reprod. 71 (5): 1699–705. doi:10.1095/biolreprod.104.030437. PMID 15269099.
  • Lachmann M, Gelbmann D, Kálmán E; et al. (2004). "PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome". Int. J. Cancer. 112 (1): 51–60. doi:10.1002/ijc.20326. PMID 15305375.
  • Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.
  • Kozma N, Halasz M, Palkovics T, Szekeres-Bartho J (2006). "The progesterone-induced blocking factor modulates the balance of PKC and intracellular Ca". Am. J. Reprod. Immunol. 55 (2): 122–9. doi:10.1111/j.1600-0897.2005.00337.x. PMID 16433831.

Template:WikiDoc Sources